InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Flowers Cynthia Louise, Directeur. Insider active across 5 companies, notably Kadmon Holdings, Inc.. Aggregated, 10 disclosures have been logged. History available since 8 November 2021. The latest transaction was disclosed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Cynthia Louise Flowers is Director at LISATA THERAPEUTICS, INC., G1 Therapeutics, Inc., Caladrius Biosciences, INC., and Kadmon Holdings, Inc. She has 10 filings in total, and across the 10 sampled filings, the most common transaction nature is attribution, with a date range from 2021-11-09 to 2026-01-13. The buy and sell amounts are both 0 in this recent sample.